The role of StAR-D3 in HER2 overexpressing breast cancer
<p>Background: HER2 overexpression in breast cancer is associated with poor prognosis. Trastuzumab is an anti-HER2 therapy and its clinical benefits have been established both in metastatic and early disease. However, Trastuzumab resistance is a common problem, even for patients who initially...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2012
|
| Subjects: |